评「纵向数据临床试验分析的新型非线性模型:使用SAS进行频率学派与贝叶斯方法的教程」
该评论文章针对临床试验纵向数据非线性比例效应模型提出质疑,指出此类模型假定比例治疗效应随时间恒定,违背假定时可致偏倚和I类错误膨胀;即使假定成立,模型仍有偏倚且推断对治疗组标记敏感,偏倚常利于活性组并增加I类错误,也可能妨碍危害检测带来安全性担忧。
要点
- 非线性纵向比例效应模型假定比例治疗效应随时间恒定,违背时可致偏倚和I类错误膨胀。
- 即使比例效应假定成立,这些模型仍有偏倚,推断对治疗组标记敏感。
- 偏倚通常有利于活性组并膨胀I类错误,可能采用单侧检验;反之可能难以检测治疗危害。
核心结论
- 非线性纵向比例效应模型在假定违背时可致偏倚和I类错误膨胀,即使假定成立也存在偏倚和推断对治疗组标记敏感的问题。
主要发现
- 这些模型假定比例治疗效应随时间恒定,违背该假定时可导致偏倚和I类错误膨胀。
- 即使比例效应假定成立,这些模型仍有偏倚,其推断对治疗组标记敏感。
- 偏倚通常有利于活性组、膨胀I类错误并可能导致单侧检验,反之可能难以检测治疗危害,带来安全性担忧。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nonlinear longitudinal proportional effect models have been proposed to improve power and provide direct estimates of the proportional treatment effect in randomized clinical trials. These models assume a fixed proportional treatment effect over time, which can lead to bias and Type I error inflation when the assumption is violated. Even when the proportional effect assumption holds, these models are biased, and their inference is sensitive to the labeling of treatment groups. Typically, this bias favors the active group, inflates Type I error, and can result in one-sided testing. Conversely, the bias can make it more difficult to detect treatment harm, creating a safety concern.
引用
- Donohue MC, Insel PS, Langford O, et al. Comments on "Novel Non-Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods". Stat Med. 2025. PMID: 40553468. doi:10.1002/sim.70058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。